What shall we do with the damaged proteins in lung disease? Ask the proteasome!

Area of Science:

• Cellular Biology
• Pulmonary Medicine
• Molecular Medicine

Background:

• The proteasome is central to cellular protein quality control, alongside endoplasmic reticulum stress and autophagy.
• It plays a crucial role in cellular protein waste disposal and recycling.
• Proteasome function is implicated in various physiological and pathological processes.

Purpose of the Study:

• To explore the proteasome's role in lung pathogenesis and its potential as a therapeutic target.
• To investigate the proteasome's involvement in lung cancer, cystic fibrosis, and chronic obstructive pulmonary disease (COPD).
• To examine the consequences of proteasomal dysfunction in chronic lung diseases.

Main Methods:

• Literature review and synthesis of existing research on proteasome function in lung biology and disease.
• Analysis of the proteasome's role in specific lung conditions such as lung cancer, cystic fibrosis, and COPD.
• Examination of the molecular mechanisms linking proteasomal dysfunction to lung pathogenesis.

Main Results:

• The proteasome is a promising therapeutic target for lung cancer, pulmonary fibrosis, and asthma.
• In cystic fibrosis, proteasomal degradation of CFTR impacts lung epithelial cell function.
• COPD is associated with downregulated proteasome activity, impaired signaling mediator degradation, and compromised cellular function.

Conclusions:

• Proteasome dysfunction represents a novel pathomechanism in chronic lung diseases.
• Accumulation of misfolded proteins and cellular stress due to proteasomal dysfunction exacerbate lung disease.
• Further therapeutic exploration of the proteasome in chronic lung diseases is warranted.